Tenascin-C is expressed in abdominal aortic aneurysm tissue with an active degradation process

Pathology International

Volumn 61, Issue 10, 2011, Pages 559-564

  Kimura, Taizo ^a,b,d   Yoshimura, Koichi ^a,c   Aoki, Hiroki ^a,e   Imanaka Yoshida, Kyoko ^f,g   Yoshida, Toshimichi ^f,g   Ikeda, Yasuhiro ^a,b   Morikage, Noriyasu ^c   Endo, Hisako ^h   Hamano, Kimikazu ^c   Imaizumi, Tsutomu ^e   Hiroe, Michiaki ^h   Aonuma, Kazutaka ^d   Matsuzaki, Masunori ^a,b  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Department of Medicine and Clinical Science ^*  (Japan)

^c YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

^e KURUME UNIVERSITY   (Japan)

^f MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g MIE UNIVERSITY   (Japan)

^h NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Aneurysm; Aorta; Biomarkers; Inflammation; Smooth muscle cells; Tenascin C

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA GALACTOSIDASE; CD68 ANTIGEN; GELATINASE B; TENASCIN;

ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; TISSUE INJURY; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; BIOLOGICAL MARKERS; CALCIUM CHLORIDE; DISEASE MODELS, ANIMAL; HUMANS; MATRIX METALLOPROTEINASE 9; MICE; MUSCLE, SMOOTH, VASCULAR; TENASCIN;

EID: 80053311571     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2011.02699.x     Document Type: Article

References (29)

1. Yamagishi M, Higashikata T, Ishibashi-Ueda H etal. Sustained upregulation of inflammatory chemokine and its receptor in aneurysmal and occlusive atherosclerotic disease: Results form tissue analysis with cDNA macroarray and real-time reverse transcriptional polymerase chain reaction methods. Circ J 2005; 69: 1490-95.
2. Pyo R, Lee JK, Shipley JM etal. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2000; 105: 1641-9.
3. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 2002; 110: 625-32.
4. Yoshimura K, Aoki H, Ikeda Y etal. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat Med 2005; 11: 1330-38.
5. Brewster DC, Cronenwett JL, Hallett JW, Jr, Johnston KW, Krupski WC, Matsumura JS. Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J Vasc Surg 2003; 37: 1106-17.
6. Aoki H, Yoshimura K, Matsuzaki M. Turning back the clock: Regression of abdominal aortic aneurysms via pharmacotherapy. J Mol Med 2007; 85: 1077-88.
7. Hellenthal FA, Buurman WA, Wodzig WK, Schurink GW. Biomarkers of AAA progression. Part 1: Extracellular matrix degeneration. Nat Rev Cardiol 2009; 6: 464-74.
8. Mackie EJ, Scott-Burden T, Hahn AW etal. Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin II. Am J Pathol 1992; 141: 377-88.
9. Chiquet-Ehrismann R, Tannheimer M, Koch M etal. Tenascin-C expression by fibroblasts is elevated in stressed collagen gels. J Cell Biol 1994; 127: 2093-101.
10. Imanaka-Yoshida K, Hiroe M, Nishikawa T etal. Tenascin-C modulates adhesion of cardiomyocytes to extracellular matrix during tissue remodeling after myocardial infarction. Lab Invest 2001; 81: 1015-24.
11. Chiquet-Ehrismann R, Chiquet M. Tenascins: Regulation and putative functions during pathological stress. J Pathol 2003; 200: 488-99.
12. Midwood KS, Orend G. The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal 2009; 3: 287-310.
13. Satta J, Soini Y, Pollanen R, Paakko P, Juvonen T. Tenascin expression is associated with a chronic inflammatory process in abdominal aortic aneurysms. J Vasc Surg 1997; 26: 670-75.
14. Paik DC, Fu C, Bhattacharya J, Tilson MD. Ongoing angiogenesis in blood vessels of the abdominal aortic aneurysm. Exp Mol Med 2004; 36: 524-33.
15. Saga Y, Yagi T, Ikawa Y, Sakakura T, Aizawa S. Mice develop normally without tenascin. Genes Dev 1992; 6: 1821-31.
16. Imanaka-Yoshida K, Matsumoto K, Hara M, Sakakura T, Yoshida T. The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse. Differentiation 2003; 71: 291-8.
17. Sawada Y, Onoda K, Imanaka-Yoshida K etal. Tenascin-C synthesized in both donor grafts and recipients accelerates artery graft stenosis. Cardiovasc Res 2007; 74: 366-76.
18. Zempo N, Kenagy RD, Au YP etal. Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. J Vasc Surg 1994; 20: 209-17.
19. Imanaka-Yoshida K, Hiroe M, Yasutomi Y etal. Tenascin-C is a useful marker for disease activity in myocarditis. J Pathol 2002; 197: 388-94.
20. Morimoto S, Imanaka-Yoshida K, Hiramitsu S etal. Diagnostic utility of tenascin-C for evaluation of the activity of human acute myocarditis. J Pathol 2005; 205: 460-67.
21. Wallner K, Li C, Shah PK etal. Tenascin-C is expressed in macrophage-rich human coronary atherosclerotic plaque. Circulation 1999; 99: 1284-9.
22. Sakalihasan N, Van Damme H, Gomez P etal. Positron emission tomography (PET) evaluation of abdominal aortic aneurysm (AAA). Eur J Vasc Endovasc Surg 2002; 23: 431-6.
23. Greenhalgh RM, Brown LC, Powell JT, Thompson SG, Epstein D, Sculpher MJ. Endovascular versus open repair of abdominal aortic aneurysm. N Engl J Med 2010; 362: 1863-71.
24. Hellenthal FA, Buurman WA, Wodzig WK, Schurink GW. Biomarkers of abdominal aortic aneurysm progression. Part 2: Inflammation. Nat Rev Cardiol 2009; 6: 543-52.
25. Odaka K, Uehara T, Arano Y etal. Noninvasive detection of cardiac repair after acute myocardial infarction in rats by 111 In Fab fragment of monoclonal antibody specific for tenascin-C. Int Heart J 2008; 49: 481-92.
26. Sato M, Toyozaki T, Odaka K etal. Detection of experimental autoimmune myocarditis in rats by 111In monoclonal antibody specific for tenascin-C. Circulation 2002; 106: 1397-402.
27. Sato A, Aonuma K, Imanaka-Yoshida K etal. Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction. J Am Coll Cardiol 2006; 47: 2319-25.
28. Terasaki F, Okamoto H, Onishi K etal. Higher serum tenascin-C levels reflect the severity of heart failure, left ventricular dysfunction and remodeling in patients with dilated cardiomyopathy. Circ J 2007; 71: 327-30.
29. Fujimoto N, Onishi K, Sato A etal. Incremental prognostic values of serum tenascin-C levels with blood B-type natriuretic peptide testing at discharge in patients with dilated cardiomyopathy and decompensated heart failure. J Card Fail 2009; 15: 898-905.